Haipuri (002399.SZ) announced that the company's wholly-owned subsidiary, Shenzhen Tiandao Pharmaceutical Co., Ltd. (abbreviated as “Tiandao...
Zhitong Finance App News, Hyperui (002399.SZ) announced that Shenzhen Tiandao Pharmaceutical Co., Ltd. (“Tiandao Pharmaceutical”), a wholly-owned subsidiary of the company, recently received an approval notice for enoxaparin sodium injections issued by the New Zealand Drug and Medical Device Safety Authority (MEDSAFE).
This approval means that Hypree's enoxaparin sodium preparations can be sold in the New Zealand market, which will further increase the global market share of the company's enoxaparin sodium preparations.